封面
市場調查報告書
商品編碼
1829782

2025年全球肺部給藥設備市場報告

Pulmonary Drug Delivery Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,肺部給藥設備市場規模強勁成長,從2024年的495.2億美元增加至2025年的528億美元,複合年成長率為6.6%。這段時期的成長可歸因於慢性阻塞性肺病(COPD)、氣喘和囊腫纖維化等呼吸系統疾病的盛行率不斷上升、全球人口老化、人們對呼吸衛生重要性的認知不斷提高、新興國家醫療保健支出不斷增加以及居家照護呼吸治療的普及率不斷提高。

預計未來幾年肺部給藥裝置市場將強勁成長,到 2029 年將達到 681.8 億美元,年複合成長率(CAGR)為 6.6%。預測期內的成長可歸因於呼吸護理中對個人化和精準醫療的需求不斷成長、家庭醫療保健服務和遠端患者監護的擴展、研發投資的增加以及對預防保健和早期療育策略的更多關注。預測期內的主要趨勢包括技術創新、向基於價值的護理模式和以患者為中心的方法的轉變、將遠端醫療和遠端監控功能整合到呼吸治療平台、使用穿戴式裝置和行動應用程式進行呼吸疾病自我管理,以及採用 3D 列印和數位製造技術。

肺部給藥裝置是一種用於將藥物直接輸送至肺部的吸入裝置。這些裝置能夠實現標靶給藥,以治療氣喘和慢性阻塞性肺病(COPD) 等呼吸系統疾病。肺部給藥也能促進胰島素和止痛藥等藥物的全身性吸收。

肺部給藥裝置的主要類型包括乾粉吸入器、定量吸入器和霧化器。乾粉吸入器將定量的藥物以細乾粉的形式分配,患者可直接吸入肺部。這類裝置用於治療氣喘、囊腫纖維化和慢性阻塞性肺病等疾病。它們透過零售藥局、醫院藥局和電商等管道銷售。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供肺部給藥裝置市場統計數據,例如全球市場規模、區域佔有率、肺部給藥裝置市場佔有率的競爭對手、詳細的肺部給藥裝置細分市場、市場趨勢以及肺部給藥裝置行業的商機。這些肺部給藥裝置市場研究報告對該行業的現狀和未來情況進行了詳細分析,為您提供所需的一切資訊的完整展望。

未來五年6.6%的預測成長率,較我們先前對該市場的預測略有下降0.5%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國,具體表現為對主要從英國和韓國進口的振動篩孔式噴霧器板和劑量計數裝置的關稅上調,從而提高呼吸系統藥物輸送的成本。此外,由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛地顯現。

預計呼吸系統疾病的日益普及將推動未來肺部給藥裝置市場的成長。呼吸系統疾病是一種影響肺部和呼吸道並損害人類呼吸的疾病或狀況。呼吸系統疾病盛行率的上升歸因於多種因素,包括空氣污染水平上升、吸煙率上升、都市化、氣候變遷和人口老化。肺部給藥裝置透過將藥物直接輸送到肺部,在治療呼吸系統疾病中發揮關鍵作用。例如,2024 年 5 月,美國國家公共衛生機構疾病管制與預防中心 (CDC) 報告稱,目前 18 歲及以上成年人氣喘的盛行率從 2021 年的 8.0% 上升到 2022 年的 8.7%。因此,預計呼吸系統疾病盛行率的上升將推動肺部給藥裝置市場的成長。

肺部給藥設備市場的主要企業正在開發創新產品,例如小容量霧化器,以便透過先進功能更好地服務客戶。小容量霧化器 (SVN) 是醫療設備,用於將液體藥物以氣溶膠霧的形式輸送給患有氣喘、慢性阻塞性肺病) 和囊腫纖維化等呼吸系統疾病的患者。例如,2024 年 5 月,美國醫療保健公司 Medline Industries, LP 推出了Hudson RCI Turbo Mist 小容量霧化器。這種突破性設備旨在短短三分鐘內輸送藥物。與標準霧化器相比,這款創新霧化器每分鐘可輸送 2.5 倍以上的藥物,將治療時間縮短約 70%。治療時間的減少使醫療保健提供者受益,因為它可以透過縮短治療時間來最佳化患者吞吐量並改善患者體驗。

2022年8月,瑞士製藥公司山德士集團(Sandoz Group AG)收購了Coalesce Product Development Limited,收購金額未揭露。山德士旨在透過此次收購增強其抽吸治療產品組合,並改善患者獲得高品質、複雜治療方法。 Coalesce Product Development Limited總部位於英國,提供肺部給藥裝置。

肺部給藥設備市場的主要參與者包括美敦力公司、液化空氣公司、碧迪公司、荷蘭皇家飛利浦公司、Medline Industries Inc.、ResMed Inc.、Dragerwerk AG And Co.KGaA、Smiths Group plc、AptarGroup Inc.、Chiesi Farmaceutici. Inc.、Drive DeVilbiss Healthcare Inc.、Hovione、Hamilton Medical AG、GaleMed Corporation、Allied Healthcare Products Inc.、Precision Medical Inc.、Salter Labs Inc. 和 Nidek Medical Products Inc.。

2024 年,北美是肺部給藥裝置市場最大的地區。肺部給藥裝置市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

肺部給藥裝置市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。

肺部給藥設備市場包括噴射霧化器、超音波霧化器和振動網狀霧化器的銷售。該市場的數據為“出廠價”,即產品製造商或生產商向其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接向最終客戶的銷售。該市場的商品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球肺部給藥裝置:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 最終用途產業分析
  • 全球肺部給藥裝置市場:成長率分析
  • 全球肺部給藥設備市場表現:規模與成長,2019-2024
  • 全球肺部給藥設備市場預測:規模與成長,2024-2029年,2034年
  • 全球肺部給藥裝置:總目標市場(TAM)

第6章 市場細分

  • 全球肺部給藥設備市場:依產品類型、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 乾粉吸入器
  • 定量噴霧吸入器
  • 噴霧器
  • 全球肺部給藥設備市場:應用、績效及預測(2019-2024年、2024-2029年、2034年)
  • 氣喘
  • 囊腫纖維化
  • 慢性阻塞性肺病
  • 其他用途
  • 全球肺部給藥設備市場:依分銷管道、實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 零售藥局
  • 醫院藥房
  • 電子商務
  • 全球肺部給藥設備市場:按乾粉吸入器(DPI)細分,類型,實際和預測,2019-2024 年,2024-2029 年,2034 年
  • 單劑量DPI
  • 多劑量DPI
  • 全球肺部給藥設備市場:定量噴霧吸入器(MDI) 細分,類型,實際及預測,2019-2024 年,2024-2029 年,2034 年
  • 含氯氟烴的MDI
  • 基於HFA的MDI
  • 全球肺部給藥設備市場:依霧化器類型細分,實際及預測,2019-2024 年、2024-2029 年、2034 年
  • 噴射霧化器
  • 超音波霧化器
  • 網狀霧化器

第7章 區域和國家分析

  • 全球肺部給藥裝置市場:區域分析、預測與成長,2019-2024 年、2024-2029 年、2034 年
  • 全球肺部給藥設備市場:國家、績效及預測(2019-2024 年、2024-2029 年及 2034 年)

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章:西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章:俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 肺部給藥設備市場:競爭格局
  • 肺部給藥裝置市場:公司簡介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Air Liquide SA Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • ResMed Inc.
  • Dragerwerk AG And Co. KGaA
  • Smiths Group plc
  • AptarGroup Inc.
  • Chiesi Farmaceutici SpA
  • Teleflex Incorporated
  • Masimo Corporation
  • Fisher And Paykel Healthcare Limited
  • Invacare Corporation
  • Vyaire Medical Inc.
  • Inogen Inc.
  • Drive DeVilbiss Healthcare Inc.
  • Hovione
  • Hamilton Medical AG
  • GaleMed Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029年肺部給藥設備市場:提供新機會的國家
  • 2029年肺部給藥設備市場:細分市場將帶來新機會
  • 2029年肺部給藥設備市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31038u

Pulmonary drug delivery devices are inhalation devices designed to administer medications directly to the lungs. These devices enable targeted drug delivery for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery allows for the systemic absorption of drugs such as insulin and pain medications.

The primary types of pulmonary drug delivery devices include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers dispense a measured dose of medication in a fine, dry powder form that the patient inhales directly into their lungs. These devices are used for conditions such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others. They are distributed through channels such as retail pharmacies, hospital pharmacies, and e-commerce.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides pulmonary drug delivery devices market statistics, including the pulmonary drug delivery devices industry global market size, regional shares, competitors with pulmonary drug delivery devices market share, detailed pulmonary drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. These pulmonary drug delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $49.52 billion in 2024 to $52.8 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy.

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $68.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.

The forecast of 6.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on vibrating mesh nebulizer plates and dose-counting mechanisms, mainly imported from the UK and South Korea, raising costs for respiratory medication administration.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market in the future. Respiratory disorders are diseases or conditions that affect the lungs and airways, impairing human respiration. The increasing prevalence of respiratory disorders is due to several factors, such as rising levels of air pollution, increased smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices play a crucial role in treating respiratory disorders by enabling direct medication delivery to the lungs. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that the prevalence of current asthma among adults aged 18 and over increased from 8.0% in 2021 to 8.7% in 2022. Thus, the rising prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market.

Major companies in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of an aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries, LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

In August 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. Through this acquisition, Sandoz aims to strengthen its portfolio of respiratory medicines and improve patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company that provides pulmonary drug delivery devices.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pulmonary drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pulmonary drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Application: Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Other Applications
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E-Commerce
  • Subsegments:
  • 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
  • 2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson and Company; Koninklijke Philips N.V.; Medline Industries Inc.; ResMed Inc.; Dragerwerk AG And Co. KGaA; Smiths Group plc; AptarGroup Inc.; Chiesi Farmaceutici S.p.A.; Teleflex Incorporated; Masimo Corporation; Fisher And Paykel Healthcare Limited; Invacare Corporation; Vyaire Medical Inc.; Inogen Inc.; Drive DeVilbiss Healthcare Inc.; Hovione; Hamilton Medical AG; GaleMed Corporation; Allied Healthcare Products Inc.; Precision Medical Inc.; Salter Labs Inc.; Nidek Medical Products Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pulmonary Drug Delivery Devices Market Characteristics

3. Pulmonary Drug Delivery Devices Market Trends And Strategies

4. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pulmonary Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pulmonary Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM)

6. Pulmonary Drug Delivery Devices Market Segmentation

  • 6.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Cystic Fibrosis
  • Chronic Obstructive Pulmonary Disease
  • Other Applications
  • 6.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce
  • 6.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose DPIs
  • Multi-Dose DPIs
  • 6.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CFC-Based MDIs
  • HFA-Based MDIs
  • 6.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Drug Delivery Devices Market

  • 8.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Drug Delivery Devices Market

  • 9.1. China Pulmonary Drug Delivery Devices Market Overview
  • 9.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Drug Delivery Devices Market

  • 10.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Drug Delivery Devices Market

  • 11.1. Japan Pulmonary Drug Delivery Devices Market Overview
  • 11.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Drug Delivery Devices Market

  • 12.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Drug Delivery Devices Market

  • 13.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Drug Delivery Devices Market

  • 14.1. South Korea Pulmonary Drug Delivery Devices Market Overview
  • 14.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Drug Delivery Devices Market

  • 15.1. Western Europe Pulmonary Drug Delivery Devices Market Overview
  • 15.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Drug Delivery Devices Market

  • 16.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Drug Delivery Devices Market

  • 17.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Drug Delivery Devices Market

  • 18.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Drug Delivery Devices Market

  • 19.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Drug Delivery Devices Market

  • 20.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Drug Delivery Devices Market

  • 21.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Drug Delivery Devices Market

  • 22.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Drug Delivery Devices Market

  • 23.1. North America Pulmonary Drug Delivery Devices Market Overview
  • 23.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Drug Delivery Devices Market

  • 24.1. USA Pulmonary Drug Delivery Devices Market Overview
  • 24.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Drug Delivery Devices Market

  • 25.1. Canada Pulmonary Drug Delivery Devices Market Overview
  • 25.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Drug Delivery Devices Market

  • 26.1. South America Pulmonary Drug Delivery Devices Market Overview
  • 26.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Drug Delivery Devices Market

  • 27.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Drug Delivery Devices Market

  • 28.1. Middle East Pulmonary Drug Delivery Devices Market Overview
  • 28.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Drug Delivery Devices Market

  • 29.1. Africa Pulmonary Drug Delivery Devices Market Overview
  • 29.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Pulmonary Drug Delivery Devices Market Competitive Landscape
  • 30.2. Pulmonary Drug Delivery Devices Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. ResMed Inc.
  • 31.2. Dragerwerk AG And Co. KGaA
  • 31.3. Smiths Group plc
  • 31.4. AptarGroup Inc.
  • 31.5. Chiesi Farmaceutici S.p.A.
  • 31.6. Teleflex Incorporated
  • 31.7. Masimo Corporation
  • 31.8. Fisher And Paykel Healthcare Limited
  • 31.9. Invacare Corporation
  • 31.10. Vyaire Medical Inc.
  • 31.11. Inogen Inc.
  • 31.12. Drive DeVilbiss Healthcare Inc.
  • 31.13. Hovione
  • 31.14. Hamilton Medical AG
  • 31.15. GaleMed Corporation

32. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

34. Recent Developments In The Pulmonary Drug Delivery Devices Market

35. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Pulmonary Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pulmonary Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pulmonary Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer